HF Advisory Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.05M | Buy |
18,520
+1,580
| +9% | +$175K | 0.81% | 44 |
|
|
2025
Q1 | $1.9M | Buy |
16,940
+764
| +5% | +$85.6K | 0.83% | 40 |
|
|
2024
Q4 | $1.49M | Sell |
16,176
-1,737
| -10% | -$160K | 0.69% | 55 |
|
|
2024
Q3 | $1.5M | Sell |
17,913
-277
| -2% | -$23.2K | 0.7% | 52 |
|
|
2024
Q2 | $1.25M | Buy |
18,190
+2,724
| +18% | +$187K | 0.65% | 57 |
|
|
2024
Q1 | $1.13M | Buy |
15,466
+639
| +4% | +$46.8K | 0.63% | 60 |
|
|
2023
Q4 | $1.2M | Buy |
14,827
+308
| +2% | +$25K | 0.77% | 46 |
|
|
2023
Q3 | $1.09M | Buy |
14,519
+1,769
| +14% | +$133K | 0.81% | 46 |
|
|
2023
Q2 | $983K | Buy |
12,750
+2,219
| +21% | +$171K | 0.78% | 47 |
|
|
2023
Q1 | $874K | Buy |
10,531
+1,626
| +18% | +$135K | 0.78% | 46 |
|
|
2022
Q4 | $764K | Buy |
+8,905
| New | +$764K | 0.77% | 49 |
|